The Bedford Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential resource for hundreds of thousands of investors across the country.

Arch Coal Inc. (NYSE: ACI) shares have rallied over 10 percent in the past week, but are still down nearly 45 percent in the past year. The International Energy Agency has recently predicted that by 2017 coal will rival oil as the world's top energy source.

Find out more about Arch Coal including full access to the free equity report at: www.BedfordReport.com/ACI

Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS) was one of the top performers in the Biotech Industry Friday gaining 8.7 percent on over 400,000 shares traded. Credit Suisse has recently initiated coverage on the company with a "outperform" rating and a price target of $7.00.

Find out more about Sunesis Pharmaceuticals including full access to the free equity report at: www.BedfordReport.com/SNSS

Standard Pacific Corp. (NYSE: SPF) U.S. homebuilders have been some of the strongest performers on the market. The U.S. housing market recovery has continued in 2013 as U.S. home prices gained 7.4 percent year-over-year in November, the largest gain seen in 6.5 years. Shares of Standard Pacific have nearly doubled in the past year.

Find out more about Standard Pacific including full access to the free equity report at: www.BedfordReport.com/SPF

U.S. Energy Corp. (NASDAQ: USEG) shares gained 9.15 percent and hit a high of $1.84 Friday. The company saw volume of 1.03 million shares traded, which was more than 10 times the average daily volume. The company earlier this month announced details of their $32.5 million 2013 capital expenditure budget.

Find out more about U.S. Energy including full access to the free equity report at: www.BedfordReport.com/USEG

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein.

A third party, Providence Media Strategies LLC has paid Equity News Circuit four hundred and fifty dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release. Neither Equity News Circuit nor the hiring party are a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security.

Contact Information: Equity News Circuit Email Contact

Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Sunesis Pharmaceuticals Charts.
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Sunesis Pharmaceuticals Charts.